Accelerating Clinical Research with a Suite of Comprehensive Services
Our in-house medical, regulatory and operational experts work collaboratively to support your Phase IIb-III clinical trials. We combine scientific leadership with disciplined execution, global access to patients, and local and global regulatory expertise to accelerate your compound to approval.
Key Differentiators
- Full-time physicians provide strategic direction for study design and planning, train operations staff, work with primary investigators, provide medical monitoring, and meet with regulatory agencies
- Strategic regulatory leadership guides trial design and execution recommendations
- Long-standing interactions at the medical and operational levels with global key academic opinion leaders and key sites including preferred CRO status at specific sites
- Close collaborations and ongoing programs with high recruiting sites at academic, network, and independent centers
- Dedicated global regulatory submissions teams experienced in key therapeutic and specialty area trial application processes and site start-up
- In-house contract attorneys to expedite contract negotiations and final execution
- Proprietary, integrated clinical study management technology platform facilitates efficient execution of global trials
- Experienced in Data Safety Monitoring Committee management as well as providing ongoing statistical support
- Detailed country and site selection processes to use the best site mix for the program as well as ongoing tracking and site communication to maintain trial timelines
- Focused teams permit Medpace to address each program’s specific needs and to provide consistent operational excellence
- Comprehensive and rigorous internal training program for CRAs